GalNAc-T14 Antibodies

Santa Cruz Biotechnology delivers a wide array of GalNAc-T14 monoclonal antibodies for research focused on understanding this important glycosyltransferase. Multiple detection methods are supported, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA).GalNAc-T14, or N-acetylgalactosaminyltransferase 14, plays a crucial role in the biosynthesis of O-glycans, which are essential for cell signaling, adhesion, and immune response. GalNAc-T14 is involved in the modification of glycoproteins and proteoglycans, influencing various biological processes, including cell differentiation and tumor progression. Understanding GalNAc-T14 function is vital for elucidating its implications in cancer biology and other diseases. Research has shown that GalNAc-T14 expression levels can vary significantly across different tissue types. Recent studies have highlighted the significance of GalNAc-T14 in cellular development and disease progression. Investigating GalNAc-T14 activity patterns can provide valuable insights into potential therapeutic targets. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of glycosylation pathways and their impact on human health.